Article

'Glaucoma 360' slated for February

The Glaucoma Research Foundation (GRF) will present Glaucoma 360, a three-day series of events offering a ?full-compass view? of the cure, catalysts, and care of glaucoma, Feb. 2 to 4, 2012, at the Palace Hotel in San Francisco.

San Francisco-The Glaucoma Research Foundation (GRF) will present Glaucoma 360, a 3-day series of events offering a “full-compass view” of the cure, catalysts, and care of glaucoma, Feb. 2 to 4, 2012, at the Palace Hotel in San Francisco.

“Glaucoma 360 promises to bring together a confluence of top-tier glaucoma leaders from the fields of medicine, science, business, investment, philanthropy, and media with those affected by glaucoma. All proceeds will benefit [GRF] and help support research, outreach, and education,” said Andrew Iwach, MD, chairman of GRF’s board of directors, and Adrienne Graves, PhD, a member of GRF’s board of directors. The two are co-chairing the event.

Ophthalmology Times will be the global media sponsor and official publication for Glaucoma 360 events.

“We are proud to welcome the seasoned and experienced team at Ophthalmology Times,” said Thomas M. Brunner, GRF president and chief executive officer, “to ensure that all the important contributions of Glaucoma 360 participants can be shared around the world.”

Glaucoma 360 will include a benefit and awards presentation, the New Horizons forum, and a glaucoma symposium for continued medical education credit. For information on all Glaucoma 360 events, visit www.glaucoma.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.